ATOS
ATOSSA THERAPEUTICS, INC. · Healthcare
ATOSSA THERAPEUTICS, INC. (ATOS) has 10 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: May 14, 2026.
- Industry:Biotechnology
- CEO:Steven C. Quay
- Employees:16
- HQ:Seattle, WA, US
- IPO:2012-11-08
No open-market insider trades for ATOS (ATOSSA THERAPEUTICS, INC.) in the last 365 days.
Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.
Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.
Earnings: last 7 quarters
Congress trading ATOS 1 all-time
- RRep. Roger Wayne MarshallPurchase$1,001 - $15,0002017-10-25
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ATOS have?
ATOSSA THERAPEUTICS, INC. (ATOS) has 10 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 0 distinct insiders. Most recent filing: May 14, 2026.
When was the most recent SEC Form 4 filing for ATOS?
The most recent Form 4 filing for ATOS on Tracefour is dated May 14, 2026.
Can I get alerts for ATOS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ATOSSA THERAPEUTICS, INC. (ATOS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ATOSSA THERAPEUTICS, INC. is in the Healthcare sector.